AF Therapy Development Manager Long Island Long Island, New York, USA Virtual Req #2061 Thursday, April 25, 2024 Who We Are AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the

The Label Standards Specialist will be responsible for the overall visual elements of the device product labeling. This includes the pad printing, IFU graphics content, label brand standards, and alignment with appropriate external regulatory requirements. This position will be responsible for the standardization and harmonization of the product, the product IFU and the o

Hybrid Therapies Sales Manager Wisconsin Milwaukee, WI, USA Virtual Req #2063 Friday, April 26, 2024 Who We Are AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of

This position will be responsible for managing various aspects of the forecasting and S&OP processes, as well as creating and managing reports that will monitor and improve the overall efficiency and consistency of the supply chain and operations teams. This role will also be responsible for identifying and implementing ways to improve customer service, inventory investme

AF Therapy Development Manager NYC Brooklyn, NY, USA Hoboken, NJ, USA Manhattan, New York, NY, USA New York, NY, USA Virtual Req #2066 Friday, April 26, 2024 Who We Are AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around

AtriCure, Inc. is a medical device company and a leader in developing, manufacturing and selling innovative cardiac surgical ablation systems designed to create precise lesions in cardiac tissue for the treatment of atrial fibrillation, or AF, and systems for the exclusion of the left atrial appendage. Cardiothoracic surgeons are adopting AtriCure’s ablation products

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy Ablation System is the